July 31, 2008 – No major difference was found in long-term safety or efficacy between sirolimus-eluting stents (SES) and ...
Stents Drug Eluting
This channel includes news and new technology innovations for drug eluting stents (DES). These drug coated stents were developed to solve a frequent problem with bare metal stents, which can cause neointimal hyperplasia (scar tissue growth) in some patients. The antiproliferative drugs used on DES prevent the growth of tissue. One downside of DES is the requirement for patients to take long-term antiplatelet therapy to prevent the possible formation of clots on these stents. Newer generation DES use technologies help the vessels heal faster, which may allow reduce the duration of dual antiplatelet therapy (DAPT), or use a single drug, usually eliminating aspirin. This section includes news for both metallic and bioresorbable drug-eluting stents and related clinical trial data.
July 30, 2008
(Editor's note: this article was updated in March 2017 with links at the bottom to more current stent technology ...
July 09, 2008July 7, 2008 - OrbusNeich today said data recently presented at the 17th Annual Meeting of the Japanese Society of ...
July 06, 2008
Boston Scientific Corp. offers the PROMUS Everolimus-Eluting Coronary Stent System for the treatment of coronary ...
July 02, 2008June 12, 2008 – The registry arm of a clinical study to assess the safety and effectiveness of Cook Medical’s ...
June 11, 2008June 9, 2008 - Atrium Medical has begun enrollment of the first patients for their CONFIRM 1, First-in-Man (FIM) drug ...
June 08, 2008June 2, 2008 - Abbott has submitted an application for Seizo Hanbai Shonin (Marketing Authorization License) to Japan's ...
June 01, 2008May 22, 2008 - MIV Therapeutics Inc. has enrolled the first patients in the registration trial of its VESTAsync polymer ...
May 21, 2008
Feature | Ellen W. Rothschild, RN, MS
As new drug-eluting stents (DES) receive premarket approval (PMA) from the FDA, despite an abrupt downturn in the market ...
May 13, 2008
Medtronic’s Endeavor Zotarolimus-Eluting Coronary Stent System is engineered for the treatment of coronary artery ...
May 12, 2008April 25, 2008 - An everolimus-eluting stent compared with a paclitaxel-eluting stent resulted in reduced angiographic ...
April 24, 2008April 25, 2008 - The Society for Cardiovascular Angiography and Interventions (SCAI) and the American College of ...
April 24, 2008April 18, 2008 - Boston Scientific Corpo. has received approval for the sale of its TAXUS Liberte paclitaxel-eluting ...
April 17, 2008April 8, 2008 - People who are taking three or more drugs and still have high blood pressure have a condition known as ...
April 07, 2008April 8, 2008 - The government on Monday said it would raise payments next year to insurers that provide healthcare ...
April 07, 2008© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now